4

PRIMARY DOCUMENT

Company: AXIM BIOTECHNOLOGIES, INC.
Filed: February 5, 2016
Period of Report: February 5, 2016
Accession Number: 0001078782-16-002279

View Document ↗ View on SEC.gov ↗